Haiqiang Duan

机构：Harbin Medical University, Third Affiliated Hospital of Harbin Medical University

发表论文 2 篇

代表论文

• A NEK2/ZWINT–NDC80 regulatory axis drives bladder cancer progression and chemoresistance (2026 · Discover Oncology)
• An Ex Vivo Patient-Derived Tumor-Bearing Human Kidney Model Recapitulates Drug Toxicity and Metabolic Distribution (2026 · Research)